Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Spinal cord injury is related to an increased risk of multiple sclerosis: a population-based, propensity score-matched, longitudinal follow-up study.
The causal cascade to multiple sclerosis: a model for MS pathogenesis.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Nitrous oxide induced myeloneuropathy: a case report.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
[Progress of demyelinating animal models in the central nervous system].
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Scoring treatment response in patients with relapsing multiple sclerosis.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
A randomized clinical trial of valacyclovir in multiple sclerosis.
The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Tumefactive demyelination: an approach to diagnosis and management.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
B cell exchange across the blood-brain barrier in multiple sclerosis.
Pages
« first
‹ previous
…
236
237
238
239
240
241
242
243
244
…
next ›
last »